Skip to main content
Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.550
-0.290 (-5.99%)
At close: Nov 20, 2024, 4:00 PM
4.560
+0.010 (0.22%)
After-hours: Nov 20, 2024, 4:36 PM EST

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $6.87M in the quarter ending September 30, 2024, with 120.24% growth. This brings the company's revenue in the last twelve months to $24.40M, up 219.91% year-over-year. In the year 2023, Verve Therapeutics had annual revenue of $11.76M with 505.77% growth.

Revenue (ttm)
$24.40M
Revenue Growth
+219.91%
P/S Ratio
15.00
Revenue / Employee
$95,671
Employees
255
Market Cap
385.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202311.76M9.82M505.77%
Dec 31, 20221.94M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 694.97M
Revance Therapeutics 256.95M
Canopy Growth 207.63M
Akebia Therapeutics 169.88M
Sangamo Therapeutics 52.29M
Perspective Therapeutics 1.56M
4D Molecular Therapeutics 17.00K
Revenue Rankings

VERV News

More News